1. Home
  2. NVCR vs FINV Comparison

NVCR vs FINV Comparison

Compare NVCR & FINV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • FINV
  • Stock Information
  • Founded
  • NVCR 2000
  • FINV 2007
  • Country
  • NVCR Switzerland
  • FINV China
  • Employees
  • NVCR N/A
  • FINV N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • FINV Finance: Consumer Services
  • Sector
  • NVCR Health Care
  • FINV Finance
  • Exchange
  • NVCR Nasdaq
  • FINV Nasdaq
  • Market Cap
  • NVCR 2.3B
  • FINV 2.0B
  • IPO Year
  • NVCR 2015
  • FINV N/A
  • Fundamental
  • Price
  • NVCR $22.09
  • FINV $8.53
  • Analyst Decision
  • NVCR Buy
  • FINV
  • Analyst Count
  • NVCR 5
  • FINV 0
  • Target Price
  • NVCR $33.40
  • FINV N/A
  • AVG Volume (30 Days)
  • NVCR 741.8K
  • FINV 979.9K
  • Earning Date
  • NVCR 02-27-2025
  • FINV 03-17-2025
  • Dividend Yield
  • NVCR N/A
  • FINV 2.78%
  • EPS Growth
  • NVCR N/A
  • FINV N/A
  • EPS
  • NVCR N/A
  • FINV 1.19
  • Revenue
  • NVCR $577,738,000.00
  • FINV $1,837,029,436.00
  • Revenue This Year
  • NVCR $19.97
  • FINV $6.61
  • Revenue Next Year
  • NVCR $2.83
  • FINV $7.97
  • P/E Ratio
  • NVCR N/A
  • FINV $7.17
  • Revenue Growth
  • NVCR 14.63
  • FINV 2.92
  • 52 Week Low
  • NVCR $11.70
  • FINV $4.45
  • 52 Week High
  • NVCR $34.13
  • FINV $8.78
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 36.77
  • FINV 68.92
  • Support Level
  • NVCR $21.38
  • FINV $8.27
  • Resistance Level
  • NVCR $22.95
  • FINV $8.78
  • Average True Range (ATR)
  • NVCR 0.86
  • FINV 0.28
  • MACD
  • NVCR 0.01
  • FINV 0.03
  • Stochastic Oscillator
  • NVCR 34.25
  • FINV 84.73

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. It offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers Tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company provides investors with an opportunity to invest in emerging asset class-consumer loans through a variety of investment options. It generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC and its revenues are derived from within the PRC.

Share on Social Networks: